Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations
Egle Avizienyte(AstraZeneca (United Kingdom)), Andrew P. Garner(AstraZeneca (United Kingdom))
Cited by 89
Related Papers
No related papers found
Powered by citation graph analysis